News Daily News Slight Shift Seen After Calories Added to Fast-food Menus L.A. McKeown December 15, 2023
News Conference News SCCT 2023 Population Screening for Coronary Plaque: Is the Evidence Enough? Todd Neale July 31, 2023
News Daily News Both Sugary and Artificially Sweetened Drinks Linked to CVD L.A. McKeown October 28, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Daily News Pesco-Mediterranean Diet Should Be the Gold Standard, Says JACC Review Caitlin E. Cox September 15, 2020
News Conference News SCCT 2020 For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change Yael L. Maxwell July 28, 2020
News Features An Age/Old Dilemma? Pulling Senior Cardiologists From the Front During COVID-19 Todd Neale April 14, 2020
News Opinion Editor's Corner A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out Shelley Wood March 16, 2020
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News CV Risk Factors in Youth May Prove Indelible for Later CAD Marcus A. Banks July 17, 2019
News Daily News AHA Advisory Emphasizes Need for Food-System Innovation, and Proof That It Works Yael L. Maxwell May 02, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Daily News Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests Michael O'Riordan December 03, 2018
News Conference News ESC 2018 Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE Michael O'Riordan August 28, 2018
News Daily News FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests Todd Neale April 11, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017